| Gene symbol | CT83 | Synonyms | CXorf61, KK-LC-1, KKLC1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq23 | dbXrefs | |
| Description | cancer/testis antigen 83 | ||||
| GTO ID | GTC3142 |
| Trial ID | NCT05483491 |
| Disease | Breast Cancer | Lung Cancer | Stomach Cancer | Cervical Cancer |
| Altered gene | KK-LC-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | KK-LC-1 TCR-T cells |
| HLA | HLA-A*01:01 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung, and Other KK-LC-1 Positive Cancers |
| Year | 2022 |
| Country | United States |
| Company sponsor | Christian Hinrichs |
| Other ID(s) | 192004|Pro2022002198|3P30CA072720-22S1 |
| Cohort 1 | |||||||||
|
|||||||||